Literature DB >> 2217147

Construction of a novel artificial-ribozyme-releasing plasmid.

K Taira1, M Oda, H Shinshi, H Maeda, K Furukawa.   

Abstract

A novel 'active-ribozyme-releasing system' was constructed, taking advantage of the consensus sequence of a new class of ribozyme. An active ribozyme sequence, targeted for the SFL1 gene (a yeast suppressor gene for flocculation) was fused just downstream of the T7 promoter. The 3' terminus of the first ribozyme was designed to be trimmed by the second ribozyme connected to the downstream of the first active ribozyme. In vitro experiments revealed that the active ribozyme targeted to SFL1 was successfully released by the action of the second ribozyme, subsequently cleaving the SFL1 mRNA at the predetermined site. Since the first active ribozyme with a defined 3'-terminus can be produced even when a circular DNA is used as a template, this kind of construct has a potential to release an 'active ribozyme' tailored to destroy a target gene (RNA) in vivo. Moreover, the second ribozyme in this construct can be utilized as a universal pseudo-terminator for generation of any RNA transcripts inserted in place of the cassette portion of the first ribozyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217147     DOI: 10.1093/protein/3.8.733

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  6 in total

1.  Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors.

Authors:  K Taira; K Nakagawa; S Nishikawa; K Furukawa
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

2.  A triplex ribozyme expression system based on a single hairpin ribozyme.

Authors:  Guillermo Aquino-Jarquin; María Luisa Benítez-Hess; Joseph A DiPaolo; Luis M Alvarez-Salas
Journal:  Oligonucleotides       Date:  2008-09

3.  A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.

Authors:  N Yuyama; J Ohkawa; T Koguma; M Shirai; K Taira
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

4.  Activation of HIV-specific ribozyme activity by self-cleavage.

Authors:  M Ventura; P Wang; T Ragot; M Perricaudet; S Saragosti
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

5.  Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme.

Authors:  S Larsson; G Hotchkiss; M Andäng; T Nyholm; J Inzunza; I Jansson; L Ahrlund-Richter
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

6.  A hammerhead ribozyme allows synthesis of a new form of the Tetrahymena ribozyme homogeneous in length with a 3' end blocked for transesterification.

Authors:  C A Grosshans; T R Cech
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.